The effect of porosity on drug release kinetics from vancomycin microsphere/calcium phosphate cement composites

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 99 B, Issue 2, 2011, Pages 391-398

  Schnieders, Julia ^a   Gbureck, Uwe ^b   Vorndran, Elke ^b   Schossig, Michael ^c   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

antibiotic; calcium phosphate cement; composites; drug delivery; porosity

Indexed keywords

ANTIBIOTIC ACTIVITY; CALCIUM PHOSPHATE BONE CEMENT; CALCIUM PHOSPHATE CEMENT; CEMENT COMPOSITE; CEMENT MATRIX; CROSS-SECTION MORPHOLOGY; DRUG RELEASE; DRUG RELEASE KINETICS; MICRO-PARTICLES; POLYMER MICROSPHERES; POWDER TO LIQUID RATIO; RELEASE PROFILES; VANCOMYCIN;

ANTIBIOTICS; CALCIUM; CALCIUM PHOSPHATE; CEMENTS; COMPOSITE MATERIALS; DRUG DELIVERY; LIQUIDS; MICROSPHERES; PHOSPHATES; PORE SIZE; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING;

BONE CEMENT;

CALCIUM PHOSPHATE; CEMENT; MICROSPHERE; POLYGLACTIN; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; COMPOSITE MATERIAL; DRUG RELEASE; ENCAPSULATION; IN VITRO STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; POROSITY; SCANNING ELECTRON MICROSCOPY;

ANTI-BACTERIAL AGENTS; BONE CEMENTS; CALCIUM PHOSPHATES; DRUG DELIVERY SYSTEMS; HUMANS; HYDROXYAPATITES; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; OSTEOMYELITIS; POROSITY; POWDERS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 80054123256     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31910     Document Type: Article

References (35)

1. Hanssen AD, Osmon DR, Patel R,. Local antibiotic delivery systems: Where are we and where are we going? Clin Orthop Relat Res 2005; 437: 111-114. (Pubitemid 41099075)
2. Joosten U, Joist A, Gosheger G, Liljenqvist U, Brandt B, von Eiff C,. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials 2005; 26: 5251-5258. (Pubitemid 40387847)
3. de Lalla F,. Antimicrobial chemotherapy in the control of surgical infectious complications. J Chemother 1999; 11: 440-445. (Pubitemid 30029541)
4. Heizmann WR, Spencker F-B,. Antiinfektiöse Chemotherapie. Stuttgart: WVG; 2004.
5. Costerton JW,. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 2005; 437: 7-11. (Pubitemid 41099059)
6. Benoit MA, Mousset B, Delloye C, Bouillet R, Gillard J,. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int Orthop 1997; 21: 403-408. (Pubitemid 28055132)
7. Zhang X, McAuley KB, Goosen MF,. Towards prediction of release profiles of antibiotics from coated poly(DL-lactide) cylinders. J Control Release 1995; 34: 175-179.
8. Okochi H, Nakano M,. Preparation and evaluation of w/o/w type emulsions containing vancomycin. Adv Drug Deliv Rev 2000; 45: 5-26.
9. Le Ray AM, Chiffoleau S, Iooss P, Grimandi G, Gouyette A, Daculsi G, et al. Vancomycin encapsulation in biodegradable poly(epsilon-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility. Biomaterials 2003; 24: 443-449. (Pubitemid 35287516)
10. Dion A, Langman M, Hall G, Filiaggi M,. Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment. Biomaterials 2005; 26: 7276-7285. (Pubitemid 41133579)
11. Ginebra MP, Traykova T, Planell JA,. Calcium phosphate cements as bone drug delivery systems: A review. J Control Release 2006; 113: 102-110. (Pubitemid 44202359)
12. Patel S, Jiang PJ, Gbureck U, Caley R, Grover LM,. Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride. J Biomed Mater Res B 2010; 93: 51-58.
13. Ginebra MP, Traykova T, Planell JA,. Calcium phosphate cements: Competitive drug carriers for the musculoskeletal system?. Biomaterials 2006; 27: 2171-2177. (Pubitemid 41782020)
14. Gbureck U, Vorndran E, Müller FA, Barralet JE,. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J Control Rel 2007; 122: 173-180. (Pubitemid 47364748)
15. Gbureck U, Vorndran E, Barralet JE,. Vancomycin release kinetics from porous calcium phosphate ceramics comparing static and dynamic immersion conditions. Acta Biomaterialia 2008; 4: 1480-1486.
16. Blom EJ, Klein-Nulend J, Wolke JG, Waas van MAJ, Driessens FCM, Burger EH,. Transforming growth factor-b1 incorporation in a calcium phosphate bone cement: Material properties and release characteristics. J Biomed Mater Res 2001; 59: 265-272.
17. Otsuka M, Matsuda Y, Suwa Y, Fox JL, Higuchi WI,. A novel skeletal drug delivery system using a self-setting calcium phosphate cement. V. Drug release behavior from a heterogeneous drug-loaded cement containing an anticancer drug. J Pharm Sci 1994; 83: 1565-1568. (Pubitemid 24348326)
18. Bohner M, Lemaitre J, Van LP, Zambelli PY, Merkle HP, Gander B,. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J Pharm Sci 1997; 86: 565-572. (Pubitemid 27203403)
19. Qi XP, Ye JD,. Mechanical and rheological properties and injectability of calcium phosphate cement containing poly (lactic-co-glycolic acid) microspheres. Mater Sci Eng C Mater Biol Appl 2009; 29: 1901-1906.
20. Qi XP, Ye JD, Wang YJ,. Improved injectability and in vitro degradation of a calcium phosphate cement containing poly(lactide-co-glycolide) microspheres. Acta Biomaterialia 2008; 4: 1837-1845.
21. Habraken WJEM, Wolke JGC, Mikos AG, Jansen JA,. Injectable PLGA microsphere/calcium phosphate cements: Physical properties and degradation characteristics. J Biomater Sci Polym Ed 2006; 17: 1057-1074. (Pubitemid 44559975)
22. Schnieders J, Gbureck U, Thull R, Kissel T,. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 2006; 27: 4239-4249. (Pubitemid 44294361)
23. Armstrong MS, Spencer RF, Cunningham JL, Gheduzzi S, Miles AW, Learmonth ID,. Mechanical characteristics of antibiotic-laden bone cement. Acta Orthop Scand 2002; 73: 688-690. (Pubitemid 36020916)
24. Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P,. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: In vitro/in vivo studies. Eur J Pharm Biopharm 2004; 57: 207-212. (Pubitemid 38283696)
25. Gbureck U, Probst J, Thull R,. Surface properties of calcium phosphate particles for self setting bone cements. Biomol Eng 2002; 19: 51-55.
26. Gbureck U, Barralet JE, Grover LM, Spatz K, Thull R,. Ionic modification of calcium phosphate cement viscosity part I: Hypodermic injection and strength improvement of apatite cements. Biomaterials 2004; 25: 2187-2195. (Pubitemid 38102418)
27. Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P,. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 1991; 137: 167-173.
28. Ozaki T, Yoshitaka T, Kunisada T, Dan'ura T, Naito N, Inoue H,. Vancomycin-impregnated polymethylmethacrylate beads for methicillin-resistant Staphylococcus aureus (MRSA) infection: Report of two cases. J Orthop Sci 1998; 3: 163-168. (Pubitemid 28259346)
29. Takada S, Uda Y, Toguchi H, Ogawa Y,. Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers. PDA J Pharm Sci Technol 1995; 49: 180-184.
30. Bohner M, Gbureck U, Barralet JE,. Technological issues for the development of more efficient calcium phosphate bone cements: A critical assessment. Biomaterials 2005; 26: 6423-6429. (Pubitemid 41024928)
31. Weibrich G, Trettin R, Gnoth SH, Gotz H, Duschner H, Wagner W,. [Determining the size of the specific surface of bone substitutes with gas adsorption]. Mund Kiefer Gesichtschir 2000; 4: 148-152.
32. Miyata T, Endo A, Ohmori T, Akiya T, Nakaiwa M,. Evaluation of pore size distribution in boundary region of micropore and mesopore using gas adsorption method. J Colloid Interface Sci 2003; 262: 116-125. (Pubitemid 36555520)
33. Langer RS, Peppas NA,. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 1981; 2: 201-214. (Pubitemid 12195193)
34. Costa P,. An alternative method to the evaluation of similarity factor in dissolution testing. Int J Pharma 2001; 220: 77-83. (Pubitemid 32476843)
35. Finch RG, Eliopoulos GM,. Safety and efficacy of glycopeptide antibiotics. J Antimicrob Chemother 2005; 55: 5-13.